A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 1, 2015, Pages 148-154.e1

  Lutgens, Maurice ^a,b   Vermeire, Séverine ^c   Van Oijen, Martijn ^a,b   Vleggaar, Frank ^a   Siersema, Peter ^a   van Assche, Gert ^b   Rutgeerts, Paul ^b   Oldenburg, Bas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Colon cancer; Inflammation; Screening; UC

Indexed keywords

ADULT; ARTICLE; BELGIUM; CANCER RISK; CASE CONTROL STUDY; COLON DISEASE; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; INFLAMMATORY BOWEL DISEASE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; TERTIARY CARE CENTER; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL; VALIDATION STUDY; ADOLESCENT; COHORT ANALYSIS; COLORECTAL NEOPLASMS; COMPLICATION; DECISION SUPPORT SYSTEM; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; BELGIUM; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84916880002     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.06.032     Document Type: Article

References (19)

1. Herrinton L.J., Liu L., Levin T.R., et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012, 143:382-389.
2. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
3. Thomas T., Abrams K.A., Robinson R.J., et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007, 25:657-668.
4. Lakatos L., Mester G., Erdelyi Z., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12:205-211.
5. Broome U., Lofberg R., Veress B., et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995, 22:1404-1408.
6. Claessen M.M., Vleggaar F.P., Tytgat K.M., et al. High lifetime risk of cancer in primary sclerosing cholangitis. JHepatol 2009, 50:158-164.
7. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
8. Velayos F.S., Loftus E.V., Jess T., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 2006, 130:1941-1949.
9. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
10. Askling J., Dickman P.W., Karlen P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001, 120:1356-1362.
11. Farraye F.A., Odze R.D., Eaden J., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138:738-745.
12. Lutgens M.W., Vleggaar F.P., Schipper M.E., et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008, 57:1246-1251.
13. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101:1671-1675.
14. Casparie M., Tiebosch A.T., Burger G., et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007, 29:19-24.
15. Harrell F.E., Califf R.M., Pryor D.B., et al. Evaluating the yield of medical tests. JAMA 1982, 247:2543-2546.
16. Pencina M.J., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123.
17. Bergeron V., Vienne A., Sokol H., et al. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am J Gastroenterol 2010, 105:2405-2411.
18. van Schaik F.D., Ten Kate F.J., Offerhaus G.J., et al. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia. Inflamm Bowel Dis 2011, 17:1108-1116.
19. Baars J.E., Looman C.W., Steyerberg E.W., et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011, 106:319-328.